The ophthalmic technology flood
August 9th 2017Today, a visit to the commercial exhibitions of major meetings is a real show, with companies’ booths offering amazing high-tech devices that promise to address the specific needs we have in our practices. Although such technology impresses us, we seldom receive information on the evidence-based data surrounding its effectiveness, its cost-benefit analysis and the potential for obsolescence.
Exploring safety, efficacy of high-intensity focused ultrasound in glaucoma
August 9th 2017High-intensity focused ultrasound cyclocoagulation is safe and effective in most refractory glaucomatous eyes. Complete success was achieved in 80% (24/30) of treated eyes that had undergone the maximum of three procedures.
Performing cataract surgery with phaco in patients with previous implantations
July 10th 2017This case study presents the results and advantages of phacoemulsification, which Dr Dieter W Klass and his team applied after previous implantation of an iris-fixated phakic IOL (pIOL) (Artisan, Ophtec) for the correction of high myopia without explantation of the pIOL.
Glaucoma monitoring implant receives CE mark
June 20th 2017An implantable glaucoma sensor has received CE mark approval for marketing in the European Union. The sensor (Eyemate, Implandata Ophthalmic Products) can provide frequent IOP readings, informing patients and their physicians about how the pressure changes by time of day and from one day to another.
Confocal scanner gives ophthalmologists valuable new tool
April 12th 2017Most ocular structures become luminescent for a short time when exposed to a light source of appropriate wavelength; this phenomenon is known as autofluorescence (AF). AF is due to the presence of fluorescent substances called fluorophores.
12-month results with small-aperture IOL providing patients with an extended range of vision
April 12th 2017The IC-8 IOL (AcuFocus) is one of the new class of extended-depth-of-focus (EDOF) IOLs that is definitively altering the landscape of cataract surgery in Europe and around the world. Whereas monofocal and multifocal lenses have one or two distinct focal points, an EDOF-IOL creates one elongated focal point, though each lens does so in a different way.
Defining dysfunctional lens syndrome
April 1st 2017Rose is a rose is a rose is a rose--a line written (1913) by Gertrude Stein and its variations in a famous quotation are often interpreted as meaning “things are what they are--makes a statement of the law of identity, and in the post-factum age is ever more meaningful. An ophthalmologist could as well write: “Cataract is a cataract is a cataract is a cataract,” ICD-10 Code H25.0 for the diagnosis “Cataracta senilis incipiens” in its earliest stage and notably with a surgical history of more than 2,500 years.
Patients’ health jeopardized by failed ophthalmology follow-up
March 29th 2017Failure to follow-up after ophthalmology appointments can damage patients’ health, a new study suggests. “In our view, national consideration should be given to create targets for reporting how well providers are managing follow-up patients,” reported A Davis and colleagues in the journal Eye.
Aldehyde dehydrogenase implicated in mucous membrane pemphigoid
March 22nd 2017Preliminary studies suggest disulfiram could aid in the treatment of mucous membrane pemphigoid (MMP). Used topically, the drug may inhibit aldehyde deydrogenase (ALDH), which plays a key role in fibrosis, wrote JK Dart, UCL Institute of Ophthalmology, London.
Evidence weak for blue light-filtering IOLs
March 15th 2017Only weak evidence supports the use of IOLs that filter visible blue light, researchers say. “On the basis of currently available evidence, one cannot advocate for the use of blue-light-filtering IOLs over UV-only filtering IOLs,” wroite X. Li, Waterford Institute of Technology, Waterford, Ireland, and colleagues.
Global diabetes epidemic must not become epidemic of blindness
March 1st 2017The global epidemic in type 2 diabetes mellitus is of unprecedented proportions. In absolute numbers, it probably exceeds any previous epidemic in the history of mankind. There are now more than 400 million people with diabetes in the world, and the number is projected to exceed 600 million by 2030.
Protein fluorescence explored for cataract diagnosis
February 8th 2017Fluorescence of lens proteins could help understand, diagnose, and treat cataracts, researchers say.“Rather than waiting for the condition to appear, it could be possible to diagnose and monitor cataract before it forms, allowing preventative measures to be taken where possible,” said Rory Duncan of Heriot-Watt University in Edinburh, United Kingdom in a press release.
‘Real-world’ ocriplasmin macular hole closure rates lag trials
January 25th 2017Ocriplasmin (Jetrea, ThromboGenics) may achieve lower macular hole closure rates than in trials, new British and Irish data suggests. Also, “the incidence of adverse events was greater than previously reported,” wrote RJ Haynes of Bristol Eye Hospital in Bristol, United Kingdom, and colleagues in the journal Eye.
Why UK patients travel abroad for laser eye surgery
January 11th 2017More citizens from the United Kingdom are traveling abroad for laser eye procedures, according to a medical travel website. Enquiries from the United Kingdom into overseas clinics for laser procedures rose 60% in the 12 months ending November 15, 2016, according to WhatClinic.com, which lists medical clinic by location.